|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 267/10 | (2006.01) |
| C07D 413/14 | (2006.01) | ||
| C07D 413/12 | (2006.01) | ||
| C07D 417/12 | (2006.01) | ||
| A61K 31/553 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 3323814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17195612.1 |
| Date of filing the European patent application | 2015-01-23 | |
| (97) | Date of publication of the European application | 2018-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-13 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (30) | Number | Date | Country code |
| 201461931090 P | 2014-01-24 | US |
| (72) |
LÖNN, Hans, Roland, GB
CONNOLLY, Stephen, GB
SWALLOW, Steven, GB
KARLSSON, Staffan PO, SE
AURELL, Carl-Johan, SE
PONTÉN, John Fritiof, GB
DOYLE, Kevin, James, GB
VAN DE POEL, Amanda, Jane, GB
JONES, Graham, Peter, GB
WATSON, David, Wyn, GB
MACRITCHIE, Jaqueline, Anne, GB
PALMER, Nicholas, John, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | (2S)-N-[(1S)-1-ciano-2-feniletil]-1,4-oksazepan-2-karboksamidai kaip dipeptidil peptidazės 1 inhibitoriai |
| (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 11 | 289.00 EUR |
| 2026-01-23 |